These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro. Liu D; Leung KY; Lam HY; Zhang R; Fan Y; Xie X; Chan KH; Hung IF Virus Res; 2024 Jul; 345():199371. PubMed ID: 38621598 [TBL] [Abstract][Full Text] [Related]
8. A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy. Sakander N; Ahmed A; Bhardwaj M; Kumari D; Nandi U; Mukherjee D Bioorg Chem; 2024 Jun; 147():107379. PubMed ID: 38643567 [TBL] [Abstract][Full Text] [Related]
9. The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model. Abdelnabi R; Foo CS; Kaptein SJF; Zhang X; Do TND; Langendries L; Vangeel L; Breuer J; Pang J; Williams R; Vergote V; Heylen E; Leyssen P; Dallmeier K; Coelmont L; Chatterjee AK; Mols R; Augustijns P; De Jonghe S; Jochmans D; Weynand B; Neyts J EBioMedicine; 2021 Oct; 72():103595. PubMed ID: 34571361 [TBL] [Abstract][Full Text] [Related]
10. Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir. Waters MD; Warren S; Hughes C; Lewis P; Zhang F Environ Mol Mutagen; 2022 Jan; 63(1):37-63. PubMed ID: 35023215 [TBL] [Abstract][Full Text] [Related]
11. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. Jayk Bernal A; Gomes da Silva MM; Musungaie DB; Kovalchuk E; Gonzalez A; Delos Reyes V; Martín-Quirós A; Caraco Y; Williams-Diaz A; Brown ML; Du J; Pedley A; Assaid C; Strizki J; Grobler JA; Shamsuddin HH; Tipping R; Wan H; Paschke A; Butterton JR; Johnson MG; De Anda C; N Engl J Med; 2022 Feb; 386(6):509-520. PubMed ID: 34914868 [TBL] [Abstract][Full Text] [Related]
13. Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19. Painter GR; Natchus MG; Cohen O; Holman W; Painter WP Curr Opin Virol; 2021 Oct; 50():17-22. PubMed ID: 34271264 [TBL] [Abstract][Full Text] [Related]
14. Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearance among hospitalized patients with COVID-19 infection during the omicron wave in China: A retrospective cohort study. Chen Y; Lin Y; Lu H; Wu X; Pan Y; Xia A; Pang L; Ye W; Xu F Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116353. PubMed ID: 38776665 [TBL] [Abstract][Full Text] [Related]
15. Molnupiravir: A new candidate for COVID-19 treatment. Pourkarim F; Pourtaghi-Anvarian S; Rezaee H Pharmacol Res Perspect; 2022 Feb; 10(1):e00909. PubMed ID: 34968008 [TBL] [Abstract][Full Text] [Related]
16. Molnupiravir in COVID-19: A systematic review of literature. Singh AK; Singh A; Singh R; Misra A Diabetes Metab Syndr; 2021; 15(6):102329. PubMed ID: 34742052 [TBL] [Abstract][Full Text] [Related]
17. Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Imran M; Kumar Arora M; Asdaq SMB; Khan SA; Alaqel SI; Alshammari MK; Alshehri MM; Alshrari AS; Mateq Ali A; Al-Shammeri AM; Alhazmi BD; Harshan AA; Alam MT; Abida Molecules; 2021 Sep; 26(19):. PubMed ID: 34641339 [TBL] [Abstract][Full Text] [Related]
19. Virology and safety profile of Molnupiravir at three different doses for treatment of SARS-CoV-2: a systematic review and meta-analysis. Sukaina M; Shuja SH; Rehan ST; Ochani S; Sheryar M APMIS; 2024 Mar; 132(3):139-151. PubMed ID: 38288881 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Standing JF; Buggiotti L; Guerra-Assuncao JA; Woodall M; Ellis S; Agyeman AA; Miller C; Okechukwu M; Kirkpatrick E; Jacobs AI; Williams CA; Roy S; Martin-Bernal LM; Williams R; Smith CM; Sanderson T; Ashford FB; Emmanuel B; Afzal ZM; Shields A; Richter AG; Dorward J; Gbinigie O; Van Hecke O; Lown M; Francis N; Jani B; Richards DB; Rahman NM; Yu LM; Thomas NPB; Hart ND; Evans P; Andersson M; Hayward G; Hood K; Nguyen-Van-Tam JS; Little P; Hobbs FDR; Khoo S; Butler C; Lowe DM; Breuer J; Nat Commun; 2024 Feb; 15(1):1652. PubMed ID: 38396069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]